Manufacturing News of Note—Samsung Bioepis, Biogen add to biosimilars; Boehringer Ingelheim to add 105 jobs in Puerto Rico

stocks
(Pixabay)

> Biogen and Samsung Bioepis are expanding their biosimilar agreement. Story

> Croatia has taken action against NCPC Hebei Huamin Pharmaceutical over manufacturing issues. EMA

> Boehringer Ingelheim’s animal health unit will invest nearly $50 million to expand a plant in Puerto Rico and expects to add 105 jobs. Release

> Chinese biotech Akeso Pharmaceuticals will open a new GE flex facility in Guangzhou, China. Release 

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.